• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number UNK SUPERA 6F
Device Problem Break (1069)
Patient Problems Thrombosis (2100); Claudication (2550)
Event Date 10/13/2019
Event Type  Injury  
Manufacturer Narrative
Event dates estimated.The device was not returned for analysis.The lot history record (lhr) for this product could not be reviewed and a similar complaint query could not be performed because the product was not returned for evaluation and the part and lot numbers were not reported.The reported patient effects of claudication and thrombosis are listed in the supera instructions for use (ifu) as known potential patient effects of peripheral percutaneous intervention.A definitive cause for the reported claudication and thrombosis, and the relationship to the product, if any, cannot be determined.A definitive cause for the reported stent fractures could not be determined.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.The udi is unknown because the part and lot #s were not provided.Article attachment: title: early supera stent fracture in the femoropopliteal artery.
 
Event Description
It was reported through a research article identifying a patient that presented with claudication.After pre-dilatation, an unspecified 5x80mm supera self-expanding stent was implanted in the right popliteal artery.12 days later, the patient returned with claudication, thrombus, and stent fractures, which were treated with several balloons.3 days after that, the patient had claudication again, so the patient was sent to bypass surgery and is doing well.No additional information was provided.Details are listed in the attached article, titled "early supera stent fracture in the femoropopliteal artery.".
 
Manufacturer Narrative
This report is being resubmitted to ensure the enclosed attachment can be easily opened by the fda.Attachment: [cn-028925.Pdf].
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA PERIPHERAL STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9916894
MDR Text Key189470511
Report Number2024168-2020-03277
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Type of Report Initial,Followup
Report Date 07/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/02/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK SUPERA 6F
Was Device Available for Evaluation? No
Date Manufacturer Received07/20/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
.014 COMMAND GUIDE WIRE; 6F ANSEL SHEATH; CXI MICROCATHETER
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age73 YR
-
-